{"id":23203,"date":"2023-02-09T11:02:06","date_gmt":"2023-02-09T10:02:06","guid":{"rendered":"https:\/\/kymos.com\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/"},"modified":"2023-02-09T11:02:06","modified_gmt":"2023-02-09T10:02:06","slug":"un-metodo-lc-ms-ms-para-cuatro-cannabinoides","status":"publish","type":"post","link":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/","title":{"rendered":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">El cannabis y su uso medicinal han sido objeto de debate en la comunidad m\u00e9dica desde hace tiempo y las asociaciones de pacientes lo han reclamado repetidamente. Sin embargo, el cannabis era ilegal en muchos pa\u00edses y se clasificaba como droga de abuso. En los \u00faltimos a\u00f1os, la perspectiva sobre el cannabis ha cambiado y, en 2015, la FDA flexibiliz\u00f3 los requisitos regulatorios para permitir que los investigadores realizaran ensayos con CBD (cannabidiol). A finales de 2020, el Tribunal de Justicia de la Uni\u00f3n Europea dictamin\u00f3 que el CBD no es un narc\u00f3tico y, unas semanas despu\u00e9s, la Comisi\u00f3n de Estupefacientes de la ONU vot\u00f3 a favor de reclasificar el cannabis de la Lista IV a una categor\u00eda menos da\u00f1ina.   <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Dados estos cambios fundamentales, cada vez m\u00e1s empresas se interesan por el desarrollo de medicamentos a base de cannabis. Naturalmente, esto tambi\u00e9n requiere m\u00e9todos anal\u00edticos fiables, espec\u00edficos y robustos. Jos\u00e9 Antonio Legarreta, experto de Kymos en desarrollo de m\u00e9todos LC-MS\/MS, informa:  <\/span><\/p>\n<blockquote><p><span style=\"font-size: 14pt;\">Kymos ha desarrollado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y sus principales metabolitos activos. Este m\u00e9todo ha demostrado ser selectivo, lineal y cumple con los requisitos bioanal\u00edticos de precisi\u00f3n, exactitud y efecto matriz.<\/span><\/p><\/blockquote>\n<p><span style=\"font-size: 14pt;\">Los cannabinoides son sustancias presentes en la planta de cannabis que act\u00faan sobre receptores espec\u00edficos del cerebro y el cuerpo humano. Son los principales principios activos tanto de los productos medicinales derivados del cannabis como de los preparados de cannabis. Los dos m\u00e1s estudiados son el tetrahidrocannabinol (THC) y el cannabidiol (CBD).  <\/span><\/p>\n<blockquote><p><span style=\"font-size: 14pt;\">\u201cEn este m\u00e9todo nos centramos en el CBD y sus principales metabolitos\u201d, explica Jos\u00e9 Antonio. \u201cLogramos desarrollar un \u00fanico m\u00e9todo LC-MS\/MS para la determinaci\u00f3n simult\u00e1nea de cannabidiol (CBD) y sus principales metabolitos (\u03949-THC, 11-hidroxi-\u03949-THC y 11-nor-9-carboxi-\u03949-THC) en plasma humano. A partir de 200 \u00b5L de muestra de plasma y un sencillo procedimiento de precipitaci\u00f3n de prote\u00ednas mediante placas de eliminaci\u00f3n de fosfol\u00edpidos, la determinaci\u00f3n por LC-MS\/MS se realiza con un Sciex 6500+ Tripe Quadrupole (modo MRM). El m\u00e9todo ha demostrado ser selectivo, lineal y cumple con los requisitos bioanal\u00edticos de precisi\u00f3n, exactitud y efecto matriz. Finalmente, nos enorgullece haber alcanzado rangos m\u00ednimos de calibraci\u00f3n con nuestro m\u00e9todo:    <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">CBD: 0,05-50 ng\/ml<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">\u03949-THC: 0,05-50 ng\/ml<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">11-Hidroxi-\u03949-THC -THC: 0,1-100 ng\/mL<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">11-nor-9-Carboxi-\u03949-THC: 0,2-200 ng\/mL\u201d<\/span><\/p><\/blockquote>\n<p><span style=\"font-size: 14pt;\">Por supuesto, no termina aqu\u00ed. En el departamento de bioan\u00e1lisis del Grupo Kymos, trabajamos a diario para desarrollar m\u00e9todos LC-MS\/MS m\u00e1s sensibles, perfectamente adaptados al proyecto de cada cliente.   <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Si necesita ayuda con sus proyectos de cannabinoides o con el desarrollo de m\u00e9todos LC-MS\/MS, p\u00f3ngase en contacto con <a href=\"mailto:commercial@kymos.com\" data-wpel-link=\"internal\">commercial@kymos.com<\/a> . Estaremos encantados de ofrecerle asesoramiento detallado, preparar un presupuesto y ejecutar sus proyectos de forma fiable y eficiente. <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El cannabis y su uso medicinal han sido objeto de  [&#8230;]<\/p>\n","protected":false},"author":7,"featured_media":22003,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[181],"tags":[67],"class_list":["post-23203","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bioanalisis","tag-carles"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides | Kymos<\/title>\n<meta name=\"description\" content=\"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides | Kymos\" \/>\n<meta property=\"og:description\" content=\"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-09T10:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1461\" \/>\n\t<meta property=\"og:image:height\" content=\"754\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Carles Celma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carles Celma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/\"},\"author\":{\"name\":\"Carles Celma\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/#\\\/schema\\\/person\\\/3d86e112b87df4b5c1304ce33368ef23\"},\"headline\":\"Un m\u00e9todo LC-MS\\\/MS para cuatro cannabinoides\",\"datePublished\":\"2023-02-09T10:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/\"},\"wordCount\":498,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/2023-02-15_Cannabis_Banner_3_small.png\",\"keywords\":[\"carles\"],\"articleSection\":[\"Bioan\u00e1lisis\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/\",\"name\":\"Un m\u00e9todo LC-MS\\\/MS para cuatro cannabinoides | Kymos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/2023-02-15_Cannabis_Banner_3_small.png\",\"datePublished\":\"2023-02-09T10:02:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/#\\\/schema\\\/person\\\/3d86e112b87df4b5c1304ce33368ef23\"},\"description\":\"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\\\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/2023-02-15_Cannabis_Banner_3_small.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/2023-02-15_Cannabis_Banner_3_small.png\",\"width\":1461,\"height\":754,\"caption\":\"Cannabinoide LC-MS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un m\u00e9todo LC-MS\\\/MS para cuatro cannabinoides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/es\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/es\\\/#\\\/schema\\\/person\\\/3d86e112b87df4b5c1304ce33368ef23\",\"name\":\"Carles Celma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g\",\"caption\":\"Carles Celma\"},\"url\":\"https:\\\/\\\/kymos.com\\\/es\\\/news\\\/author\\\/dr-carles-celma\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides | Kymos","description":"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/","og_locale":"es_ES","og_type":"article","og_title":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides | Kymos","og_description":"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.","og_url":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/","og_site_name":"Kymos","article_published_time":"2023-02-09T10:02:06+00:00","og_image":[{"width":1461,"height":754,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png","type":"image\/png"}],"author":"Carles Celma","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"Escrito por":"Carles Celma","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/"},"author":{"name":"Carles Celma","@id":"https:\/\/kymos.com\/es\/#\/schema\/person\/3d86e112b87df4b5c1304ce33368ef23"},"headline":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides","datePublished":"2023-02-09T10:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/"},"wordCount":498,"image":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png","keywords":["carles"],"articleSection":["Bioan\u00e1lisis"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/","url":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/","name":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides | Kymos","isPartOf":{"@id":"https:\/\/kymos.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png","datePublished":"2023-02-09T10:02:06+00:00","author":{"@id":"https:\/\/kymos.com\/es\/#\/schema\/person\/3d86e112b87df4b5c1304ce33368ef23"},"description":"Kymos ha desarrollado y validado un m\u00e9todo LC-MS\/MS para el cannabidiol (CBD) y los principales metabolitos activos del CBD.","breadcrumb":{"@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2023\/02\/2023-02-15_Cannabis_Banner_3_small.png","width":1461,"height":754,"caption":"Cannabinoide LC-MS"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/es\/news\/un-metodo-lc-ms-ms-para-cuatro-cannabinoides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/es\/"},{"@type":"ListItem","position":2,"name":"Un m\u00e9todo LC-MS\/MS para cuatro cannabinoides"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/es\/#website","url":"https:\/\/kymos.com\/es\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/kymos.com\/es\/#\/schema\/person\/3d86e112b87df4b5c1304ce33368ef23","name":"Carles Celma","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7ec8bcf3304288056fadfac1c80186a100e5bc223991385f6f2e5e4c8a55099?s=96&d=mm&r=g","caption":"Carles Celma"},"url":"https:\/\/kymos.com\/es\/news\/author\/dr-carles-celma\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/posts\/23203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/comments?post=23203"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/posts\/23203\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/media\/22003"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/media?parent=23203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/categories?post=23203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/es\/wp-json\/wp\/v2\/tags?post=23203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}